Congress targets Chinese influence in health tech. It could come with tradeoffs
WASHINGTON — A California biotechnology company that helps doctors detect genetic causes for cancer is among those that could be cut out of the U.S. market over ties to China, underscoring the possible tradeoffs between health innovation and a largely bipartisan push in Congress to counter Beijing’s global influence. The competition between the world’s superpowers … Read more
